Utilization of the organ care system - a game-changer in combating donor organ shortage

Aron-Frederik Popov1, Diana García Sáez1, Anton Sabashnikov1

  • 1Department of Cardiothoracic Transplantation & Mechanical Circulatory Support, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.

Insights

Cardiac transplantation is the gold standard for end-stage heart failure, but organ scarcity is a major limitation. Ex vivo heart perfusion can recondition previously unsuitable organs, expanding donor availability for transplantation.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Surgical Innovation

Background:

  • Cardiac transplantation is the primary treatment for end-stage heart failure.
  • Limited donor organ availability significantly restricts transplantation rates.
  • Current criteria for donor heart acceptance exclude many potentially viable organs.

Purpose of the Study:

  • To explore the potential of ex vivo heart perfusion in expanding the donor heart pool.
  • To evaluate the feasibility of using organs outside standard acceptability criteria for transplantation.
  • To establish ex vivo heart perfusion as a future standard for donor organ assessment.

Main Methods:

  • Utilizing ex vivo heart perfusion technology to assess and recondition donor hearts.
  • Evaluating hearts that do not meet traditional criteria for transplantation.
  • Analyzing the outcomes of using reconditioned organs in cardiac transplantation.

Main Results:

  • Ex vivo heart perfusion has demonstrated success in reconditioning organs previously deemed unsuitable.
  • This technology has led to an increased availability of donor organs for transplantation.
  • The application of this technique broadens the scope of acceptable donor hearts.

Conclusions:

  • Ex vivo heart perfusion is a promising technology to overcome donor organ shortages in cardiac transplantation.
  • Evaluating hearts outside standard criteria using this method can significantly enhance the donor pool.
  • Wider adoption of ex vivo heart perfusion could improve outcomes for patients with end-stage heart failure awaiting transplantation.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
768
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.3K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
865
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.7K